-344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension

American Journal of Hypertension

Volumn 14, Issue 9 I, 2001, Pages 934-941

  Rossi, Ermanno ^a   Regolisti, Giuseppe ^a   Perazzoli, Franco ^a   Negro, Aurelio ^a   Davoli, Simona ^a   Nicoli, Davide ^a   Sani, Carlo ^a   Casali, Bruno ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

CYP11B2 polymorphism; Idiopathic hyperaldosteronism; Low renin essential hypertension

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CAPTOPRIL; RENIN;

ADULT; ALDOSTERONE RELEASE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERALDOSTERONISM; IDIOPATHIC DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROMOTER REGION;

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; ITALY; POLYMORPHISM, GENETIC; POTASSIUM; RENIN;

EID: 0034835966     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02138-0     Document Type: Article

References (45)

1. Genetic approach to diagnostic and therapeutic decisions in human hypertension
2. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension
3. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: A subtype of essential hypertension?
4. Renin subgroups in essential hypertension
5. Heritability of low-renin hypertension
6. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: Aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene
7. The characterization of low renin hypertension by plasma renin activity and plasma aldosterone concentration
8. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension
9. Alterations in aldosterone secretion and metabolism in low renin hypertension
10. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension
11. Control of plasma aldosterone in primary aldosteronism: Distinction between adenoma and hyperplasia
12. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism
13. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension
14. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism
15. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism
16. Adrenal scintigraphy in low renin essential hypertension
17. Mineralocorticoid hypertension
18. Primary aldosteronism. A common and curable form of hypertension
19. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension. Relation to plasma renin
20. The product of the CYP11B2 is required for aldosterone biosynthesis in the human adrenal cortex
21. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3
22. Characterization of two genes encoding human steroid 11β-hydroxylase (P45011β)
23. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism
24. Haplotype analysis of CYP11B2
25. Genetic variation in P450c11AS in Chilean patients with low renin hypertension
26. Endocrine hypertension
27. Primary aldosteronism and other forms of mineralocorticoid hypertension
28. A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type 1
29. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function
30. Structural analysis and evaluation of the aldosterone synthase gene in hypertension
31. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
32. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese
33. 173Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension
34. CYP11B2 gene polymorphism in idiopathic hyperaldosteronism
35. Aldosterone synthase gene (CYP11B2) C -344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST)
36. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population
37. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males
38. Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction
39. Genetic determination of plasma aldosterone levels in essential hypertension
40. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
41. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism
42. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients
43. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension
44. Genetic determinants of human hypertension
45. Primary aldosteronism: Adrenal venous sampling